AB
Publicaties op Oncologisch.com
Deep Learning-Derived Sarcopenia Marker Predicts Benefit from Anti-EGFR Therapy in Patients with RAS Wild-type Metast...
Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti-EGFR-Based Maintenance for RAS...
QoL bij RAS-wildtype CRC onder panitumumab versus bevacizumab: PARADIGM analyse